scispace - formally typeset
S

Shunle Chen

Researcher at Shanghai Jiao Tong University

Publications -  63
Citations -  4941

Shunle Chen is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Lupus erythematosus & Systemic lupus erythematosus. The author has an hindex of 27, co-authored 61 publications receiving 4524 citations. Previous affiliations of Shunle Chen include Renji Hospital & Chinese Academy of Sciences.

Papers
More filters
Journal ArticleDOI

Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

TL;DR: It is found that 1,25(OH)2D3 may play an important role in the maintenance of B cell homeostasis and that the correction of vitamin D deficiency may be useful in the treatment of B Cell-mediated autoimmune disorders.
Journal Article

[Expression of fusion proteins in beta(2)GP I gene-transfected HEp-2 cells and its clinical application].

TL;DR: As a new kind of substrate of IIF, beta( 2)GP I transfectant can be used to detect anti-beta(2)GP-I antibodies and keep the immunofluorescent property of HEp-2 cells in IFANA test and can be use as substrate for routine IFANA detection.
Journal ArticleDOI

MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

TL;DR: Investigation of the contribution of microRNA-146a, identified in the pilot expression profiling step, to the pathogenesis of systemic lupus erythematosus revealed a negative regulator of innate immunity, which provides potential novel strategies for therapeutic intervention.
Journal ArticleDOI

miR-155 and Its Star-Form Partner miR-155* Cooperatively Regulate Type I Interferon Production by Human Plasmacytoid Dendritic Cells

TL;DR: This study identified and validated novel miRNA-protein networks involved in regulating human plasmacytoid dendritic cell (PDC) activation, and demonstrated that miR-155* and mi-155 were inversely regulated by autocrine/paracrine type I interferon and TLR7-activated KHSRP at the posttranscriptional level.